Cosmo Pharmaceuticals N.V Free Cash Flow Generation Index
Cosmo Pharmaceuticals N.V free cash flow generation index. Cosmo Pharmaceuticals N.V (C43) has a Free Cash Flow Generation Index of 1.18x as of June 2022. Free cash flow of €7.39 Million represents 1% of operating cash flow (€6.28 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Cosmo Pharmaceuticals N.V (2016–2024)
Free cash flow generation index of Cosmo Pharmaceuticals N.V from 2016 to 2024. Historical FCF Generation Index trend for Cosmo Pharmaceuticals N.V across 6 annual periods. See C43 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cosmo Pharmaceuticals N.V Free Cash Flow Generation Index by Year (2016–2024)
Cosmo Pharmaceuticals N.V free cash flow generation index by year from 2016 to 2024. Year-by-year Free Cash Flow Generation Index for Cosmo Pharmaceuticals N.V. For the full cash flow conversion analysis, see Cosmo Pharmaceuticals N.V (C43) cash flow conversion.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.97x | €156.76 Million | €162.41 Million | €5.65 Million | ▲ +77.2% |
| 2023 | 0.54x | €18.31 Million | €33.62 Million | €15.31 Million | ▼ -30.2% |
| 2022 | 0.78x | €25.92 Million | €33.23 Million | €7.31 Million | ▲ +139.5% |
| 2021 | 0.33x | €4.11 Million | €12.61 Million | €5.49 Million | ▼ -13.7% |
| 2020 | 0.38x | €4.90 Million | €12.98 Million | €4.12 Million | ▼ -79.6% |
| 2016 | 1.85x | €40.12 Million | €21.69 Million | €18.43 Million | — |